S
ST Pharm Co Ltd
KOSDAQ:237690
ST Pharm Co Ltd
KOSDAQ:237690
Price:
86 100
KRW
0.94%
Market Closed
Market Cap:
1.7T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
ST Pharm Co Ltd
86100
+800 (+0.94%)
| 52 Week Range |
60 400
117 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
ST Pharm Co Ltd
Income Statement
Earnings Waterfall
ST Pharm Co Ltd
ST Pharm Co Ltd
|
Revenue
|
278.6B
KRW
|
|
Cost of Revenue
|
-181.4B
KRW
|
|
Gross Profit
|
97.2B
KRW
|
|
Operating Expenses
|
-70.8B
KRW
|
|
Operating Income
|
26.4B
KRW
|
|
Other Expenses
|
5.9B
KRW
|
|
Net Income
|
32.4B
KRW
|
Income Statement
ST Pharm Co Ltd
ST Pharm Co Ltd
Currency: KRW
| Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||
| Revenue |
138 052
N/A
|
151 086
+9%
|
190 495
+26%
|
198 739
+4%
|
200 362
+1%
|
217 291
+8%
|
204 252
-6%
|
193 639
-5%
|
202 800
+5%
|
183 300
-10%
|
162 381
-11%
|
132 399
-18%
|
97 738
-26%
|
85 107
-13%
|
67 420
-21%
|
74 084
+10%
|
93 257
+26%
|
97 735
+5%
|
113 385
+16%
|
115 724
+2%
|
124 109
+7%
|
131 198
+6%
|
137 778
+5%
|
161 689
+17%
|
165 642
+2%
|
175 363
+6%
|
186 130
+6%
|
200 659
+8%
|
249 322
+24%
|
262 987
+5%
|
269 638
+3%
|
264 760
-2%
|
284 992
+8%
|
286 069
+0%
|
272 887
-5%
|
278 643
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(86 785)
|
(92 936)
|
(106 955)
|
(111 589)
|
(107 370)
|
(114 197)
|
(113 116)
|
(112 818)
|
(123 018)
|
(121 578)
|
(114 926)
|
(103 760)
|
(94 959)
|
(90 078)
|
(81 517)
|
(82 449)
|
(94 885)
|
(96 310)
|
(106 465)
|
(109 058)
|
(104 123)
|
(107 021)
|
(101 734)
|
(104 898)
|
(107 899)
|
(105 361)
|
(112 942)
|
(127 883)
|
(160 390)
|
(165 587)
|
(170 177)
|
(162 267)
|
(172 876)
|
(179 999)
|
(173 818)
|
(181 441)
|
|
| Gross Profit |
51 267
N/A
|
58 151
+13%
|
83 540
+44%
|
87 150
+4%
|
92 992
+7%
|
103 093
+11%
|
91 136
-12%
|
80 820
-11%
|
79 782
-1%
|
61 721
-23%
|
47 454
-23%
|
28 638
-40%
|
2 780
-90%
|
(4 972)
N/A
|
(14 098)
-184%
|
(8 365)
+41%
|
(1 628)
+81%
|
1 426
N/A
|
6 921
+385%
|
6 667
-4%
|
19 985
+200%
|
24 177
+21%
|
36 045
+49%
|
56 791
+58%
|
57 743
+2%
|
70 003
+21%
|
73 189
+5%
|
72 776
-1%
|
88 932
+22%
|
97 400
+10%
|
99 461
+2%
|
102 493
+3%
|
112 115
+9%
|
106 070
-5%
|
99 069
-7%
|
97 202
-2%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(16 796)
|
(16 229)
|
(15 223)
|
(15 057)
|
(15 408)
|
(16 362)
|
(16 280)
|
(16 630)
|
(17 948)
|
(17 539)
|
(17 670)
|
(18 320)
|
(18 426)
|
(18 430)
|
(19 407)
|
(19 554)
|
(25 075)
|
(30 187)
|
(35 396)
|
(39 252)
|
(38 803)
|
(40 262)
|
(42 381)
|
(47 553)
|
(52 166)
|
(57 381)
|
(61 908)
|
(64 728)
|
(71 080)
|
(76 376)
|
(80 364)
|
(81 269)
|
(78 603)
|
(74 387)
|
(72 054)
|
(70 759)
|
|
| Selling, General & Administrative |
(6 410)
|
(6 430)
|
(5 716)
|
(6 189)
|
(6 758)
|
(7 537)
|
(7 517)
|
(7 597)
|
(8 150)
|
(8 034)
|
(8 291)
|
(8 896)
|
(9 472)
|
(8 887)
|
(8 977)
|
(8 883)
|
(9 494)
|
(13 098)
|
(17 121)
|
(20 308)
|
(22 998)
|
(24 789)
|
(26 117)
|
(27 941)
|
(31 091)
|
(33 438)
|
(35 454)
|
(38 325)
|
(40 278)
|
(42 192)
|
(44 728)
|
(44 678)
|
(44 748)
|
(45 099)
|
(44 742)
|
(44 496)
|
|
| Research & Development |
(10 342)
|
(9 758)
|
(9 468)
|
(8 830)
|
(8 582)
|
(8 756)
|
(8 688)
|
(8 978)
|
(9 158)
|
(9 368)
|
(9 237)
|
(9 279)
|
(8 235)
|
(9 098)
|
(9 710)
|
(9 922)
|
(14 414)
|
(15 808)
|
(16 481)
|
(16 421)
|
(12 411)
|
(12 182)
|
(12 925)
|
(16 069)
|
(17 246)
|
(19 899)
|
(22 102)
|
(21 810)
|
(25 150)
|
(28 393)
|
(29 618)
|
(30 356)
|
(28 369)
|
(23 771)
|
(21 921)
|
(20 882)
|
|
| Depreciation & Amortization |
(43)
|
(43)
|
(41)
|
(38)
|
(68)
|
(67)
|
(68)
|
(69)
|
(640)
|
(137)
|
(140)
|
(143)
|
(720)
|
(444)
|
(719)
|
(749)
|
(1 168)
|
(1 280)
|
(1 794)
|
(2 523)
|
(3 425)
|
(3 578)
|
(3 627)
|
(3 841)
|
(3 829)
|
(4 055)
|
(4 363)
|
(4 593)
|
(5 652)
|
(5 792)
|
(6 017)
|
(6 234)
|
(5 486)
|
(5 518)
|
(5 391)
|
(5 382)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
287
|
287
|
299
|
0
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
34 471
N/A
|
41 921
+22%
|
68 317
+63%
|
72 094
+6%
|
77 583
+8%
|
86 733
+12%
|
74 858
-14%
|
64 192
-14%
|
61 834
-4%
|
44 185
-29%
|
29 786
-33%
|
10 320
-65%
|
(15 646)
N/A
|
(23 402)
-50%
|
(33 504)
-43%
|
(27 919)
+17%
|
(26 703)
+4%
|
(28 760)
-8%
|
(28 474)
+1%
|
(32 584)
-14%
|
(18 817)
+42%
|
(16 083)
+15%
|
(6 336)
+61%
|
9 240
N/A
|
5 578
-40%
|
12 622
+126%
|
11 281
-11%
|
8 049
-29%
|
17 851
+122%
|
21 024
+18%
|
19 097
-9%
|
21 224
+11%
|
33 512
+58%
|
31 682
-5%
|
27 015
-15%
|
26 443
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(5 471)
|
(978)
|
(152)
|
1 563
|
4 648
|
362
|
1 804
|
2 275
|
(443)
|
(156)
|
724
|
781
|
2 994
|
3 331
|
1 996
|
3 576
|
1 806
|
3 462
|
11 563
|
8 200
|
1 578
|
236
|
(8 642)
|
(7 845)
|
(710)
|
(4 679)
|
(3 003)
|
4 599
|
1 346
|
2 140
|
0
|
(8 614)
|
(10 268)
|
(3 488)
|
1 120
|
11 462
|
|
| Non-Reccuring Items |
5 429
|
5 401
|
5 427
|
5 396
|
(19)
|
13
|
0
|
0
|
(661)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(40)
|
(49)
|
(39)
|
(39)
|
(263)
|
(255)
|
0
|
0
|
(860)
|
0
|
0
|
0
|
(658)
|
0
|
0
|
0
|
21
|
(12)
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(3 673)
|
0
|
0
|
0
|
(645)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
1 213
|
850
|
648
|
448
|
(1 454)
|
(1 331)
|
(1 508)
|
(2 369)
|
(625)
|
(1 561)
|
(2 204)
|
(1 383)
|
(81)
|
(809)
|
(181)
|
(237)
|
(96)
|
(953)
|
(873)
|
(875)
|
423
|
45
|
150
|
2 336
|
65
|
(272)
|
(1 072)
|
(3 043)
|
683
|
158
|
578
|
278
|
164
|
(1 200)
|
(1 246)
|
(1 214)
|
|
| Pre-Tax Income |
35 602
N/A
|
47 145
+32%
|
74 200
+57%
|
79 460
+7%
|
80 495
+1%
|
85 521
+6%
|
75 154
-12%
|
64 098
-15%
|
59 245
-8%
|
42 467
-28%
|
28 306
-33%
|
9 719
-66%
|
(13 391)
N/A
|
(20 880)
-56%
|
(31 690)
-52%
|
(24 582)
+22%
|
(24 973)
-2%
|
(26 265)
-5%
|
(17 784)
+32%
|
(25 259)
-42%
|
(16 825)
+33%
|
(15 802)
+6%
|
(14 827)
+6%
|
3 730
N/A
|
1 260
-66%
|
7 671
+509%
|
7 206
-6%
|
9 604
+33%
|
19 237
+100%
|
23 322
+21%
|
19 675
-16%
|
12 888
-34%
|
23 354
+81%
|
26 994
+16%
|
26 889
0%
|
36 691
+36%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||
| Tax Provision |
(10 413)
|
(13 001)
|
(19 622)
|
(20 719)
|
(19 069)
|
(20 325)
|
(17 764)
|
(15 109)
|
(14 248)
|
(10 121)
|
(6 929)
|
(2 895)
|
4 123
|
5 549
|
8 361
|
6 944
|
6 444
|
8 171
|
5 266
|
6 382
|
3 670
|
2 014
|
4 174
|
688
|
2 117
|
2 907
|
1 099
|
886
|
(1 721)
|
(5 064)
|
(3 587)
|
(3 365)
|
(5 831)
|
(6 935)
|
(7 139)
|
(6 606)
|
|
| Income from Continuing Operations |
25 189
|
34 145
|
54 579
|
58 743
|
61 426
|
65 196
|
57 391
|
48 989
|
44 997
|
32 347
|
21 377
|
6 824
|
(9 268)
|
(15 330)
|
(23 328)
|
(17 637)
|
(18 529)
|
(18 094)
|
(12 518)
|
(18 877)
|
(13 155)
|
(13 788)
|
(10 653)
|
4 418
|
3 377
|
10 579
|
8 305
|
10 490
|
17 516
|
18 259
|
16 088
|
9 523
|
17 523
|
20 059
|
19 751
|
30 085
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
319
|
729
|
1 083
|
1 008
|
723
|
12
|
(578)
|
(65)
|
(338)
|
(20)
|
490
|
484
|
1 623
|
1 722
|
2 021
|
2 058
|
1 968
|
1 955
|
2 304
|
|
| Net Income (Common) |
25 189
N/A
|
34 145
+36%
|
54 579
+60%
|
58 743
+8%
|
61 426
+5%
|
65 196
+6%
|
57 391
-12%
|
48 989
-15%
|
44 997
-8%
|
32 347
-28%
|
21 377
-34%
|
6 824
-68%
|
(9 268)
N/A
|
(15 330)
-65%
|
(23 328)
-52%
|
(17 637)
+24%
|
(18 529)
-5%
|
(17 775)
+4%
|
(11 789)
+34%
|
(17 795)
-51%
|
(12 147)
+32%
|
(13 065)
-8%
|
(10 641)
+19%
|
3 841
N/A
|
3 312
-14%
|
10 241
+209%
|
8 285
-19%
|
10 981
+33%
|
18 000
+64%
|
19 882
+10%
|
17 810
-10%
|
11 544
-35%
|
19 581
+70%
|
22 027
+12%
|
21 706
-1%
|
32 389
+49%
|
|
| EPS (Diluted) |
1 799.21
N/A
|
2 438.92
+36%
|
3 898.5
+60%
|
3 091.73
-21%
|
3 839.12
+24%
|
3 431.36
-11%
|
3 020.57
-12%
|
2 578.36
-15%
|
2 368.26
-8%
|
1 702.47
-28%
|
1 125.1
-34%
|
359.15
-68%
|
-487.78
N/A
|
-806.84
-65%
|
-1 227.78
-52%
|
-928.26
+24%
|
-975.21
-5%
|
-935.52
+4%
|
-620.47
+34%
|
-936.57
-51%
|
-639.31
+32%
|
-687.63
-8%
|
-570.35
+17%
|
205.91
N/A
|
177.5
-14%
|
544.48
+207%
|
440.47
-19%
|
583.8
+33%
|
957
+64%
|
1 057.04
+10%
|
946.9
-10%
|
613.77
-35%
|
1 041.07
+70%
|
1 163.35
+12%
|
1 115.2
-4%
|
1 662.25
+49%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
